Fabio Ynoe de Moraes: The Power of Laser Focus - Lessons from Carlos Alcaraz

Fabio Ynoe de Moraes

Anu Agrawal: The 10th Global Health Catalyst Summit to Advance Global Cancer Collaboration

Anu Agrawal

ESGO President-Elect Jalid Sehouli's Message on World Gynecologic Oncology Day 2025

Jalid Sehouli

Vincent Rajkumar: Key Takeaways From IMS25

Vincent Rajkumar, IMS25

More Than $358 Million Invested in Hope, Progress and Cures - Rally Foundation for Childhood Cancer Research

Childhood Cancer

Douglas Flora: The Ultimate Two-Person Performance Review

Douglas Flora

Top 10 Oncogrants of the Week: Fueling the Next Wave of Cancer Research and Innovation

Top 10 Oncogrants of the Week: Fueling the Next Wave of Cancer Research and Innovation

Robin Zon: ASCO Launches ASCO Edge to Strengthen Practice Management and Patient Care

Robin Zon

OncoCalendar

« All Events

  • This event has passed.

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

Dec 16, 2024 • 7:00 PM - 9:00 PM
SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC will be held on December 16th, 2024.

This exclusive course will offer the latest updates on lung cancer treatment in Southeast Asia, with a special focus on immunotherapy. In Series II, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy, the best management strategies for advanced disease, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy is set to transform the landscape of lung cancer treatment in Southeast Asia, bringing hope for improved patient outcomes.

See the Speakers and Southeast Asia Team Below:

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

Details

Date:
Dec 16, 2024
Time:
7:00 PM - 9:00 PM
Website:
https://www.iaslc.org/node/35048

Organizer

The International Association for the Study of Lung Cancer (IASLC)
Phone
1-855-464-2752
Email
info@iaslc.org